4078
Sakai Chemical Industry Co.,Ltd.
堺化学工業
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
84,918
Mar 2022
80,135
Mar 2023
83,861
Mar 2024
82,105
Mar 2025
84,409
Operating profit(million JPY)
Mar 2021
4,304
Mar 2022
7,494
Mar 2023
4,407
Mar 2024
2,942
Mar 2025
6,093
Operating profit margin(%)
Mar 2021
5.07
Mar 2022
9.35
Mar 2023
5.26
Mar 2024
3.58
Mar 2025
7.22
Profit before tax(million JPY)
Mar 2021
-2,037
Mar 2022
9,223
Mar 2023
4,977
Mar 2024
-3,703
Mar 2025
5,973
Profit(million JPY)
Mar 2021
-2,803
Mar 2022
6,747
Mar 2023
2,344
Mar 2024
-7,092
Mar 2025
5,013
Total assets(million JPY)
Mar 2021
123,007
Mar 2022
123,919
Mar 2023
128,021
Mar 2024
125,445
Mar 2025
123,319
Cash and cash equivalents(million JPY)
Mar 2021
11,153
Mar 2022
10,549
Mar 2023
12,188
Mar 2024
16,475
Mar 2025
16,153
Cash flows from operating activities(million JPY)
Mar 2021
7,826
Mar 2022
6,567
Mar 2023
773
Mar 2024
6,866
Mar 2025
12,005
Cash flows from investing activities(million JPY)
Mar 2021
-7,422
Mar 2022
-1,654
Mar 2023
-2,620
Mar 2024
-3,963
Mar 2025
-5,714
Cash flows from financing activities(million JPY)
Mar 2021
1,667
Mar 2022
-5,654
Mar 2023
3,283
Mar 2024
1,259
Mar 2025
-6,879
Return on equity(%)
Mar 2021
-3.6
Mar 2022
8.7
Mar 2023
2.9
Mar 2024
-9.2
Mar 2025
6.6
Equity ratio(%)
Mar 2021
61.6
Mar 2022
63.6
Mar 2023
62.9
Mar 2024
59.3
Mar 2025
63.5
Earnings per share(JPY per share)
Mar 2021
-166.58
Mar 2022
407.06
Mar 2023
144.85
Mar 2024
-437.65
Mar 2025
309.21
Net assets per share(JPY per share)
Mar 2021
4,502.33
Mar 2022
4,875.69
Mar 2023
4,970.11
Mar 2024
4,586.92
Mar 2025
4,825.33
Dividend per share(JPY per share)
Mar 2021
15
Mar 2022
70
Mar 2023
75
Mar 2024
70
Mar 2025
135
Payout ratio(%)
Mar 2021
-
Mar 2022
17.2
Mar 2023
51.78
Mar 2024
-
Mar 2025
43.66
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.